Leerink Swann Starts Jazz Pharmaceuticals (JAZZ) at Outperform; Compelling Risk/Reward
Tweet Send to a FriendGet Alerts JAZZ Hot Sheet
Price: $63.75 +1.19%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade JAZZ Now!
Leerink Swann initiates coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with an Outperform. PT $60.00.
Analyst, Michael Schmidt, said, "We project 2011-13 EPS CAGR of 16%, higher growth than its peers. However, JAZZ trades at a discount on a forward P/E due to concerns over sustainability of growth of its key products. We see near term appreciation as JAZZ exceeds EPS expectations driven by organic growth, applying its unique high margin business model. Not included in our model are accretive acquisitions which diversify revenues while capitalizing on its existing platform."
For an analyst ratings summary and ratings history on Jazz Pharmaceuticals click here. For more ratings news on Jazz Pharmaceuticals click here.
Shares of Jazz Pharmaceuticals closed at $44.64 yesterday, with a 52 week range of $23.50-$53.10.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Michael Schmidt, said, "We project 2011-13 EPS CAGR of 16%, higher growth than its peers. However, JAZZ trades at a discount on a forward P/E due to concerns over sustainability of growth of its key products. We see near term appreciation as JAZZ exceeds EPS expectations driven by organic growth, applying its unique high margin business model. Not included in our model are accretive acquisitions which diversify revenues while capitalizing on its existing platform."
For an analyst ratings summary and ratings history on Jazz Pharmaceuticals click here. For more ratings news on Jazz Pharmaceuticals click here.
Shares of Jazz Pharmaceuticals closed at $44.64 yesterday, with a 52 week range of $23.50-$53.10.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jazz Pharma (JAZZ) Could Be Takeout Target
- Topeka Capital Starts Spansion (CODE) at Buy
- Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
